KLOFARABİN-SIKLOFOSFAMİD PROTOKOLÜ

Kaynaklar:

1- Locatelli F, Testi AM, Bernardo ME, Rizzari C, Bertaina A, Merli P, Pession A, Giraldi E, Parasole R, Barberi W, Zecca M. Clofarabine, cyclophosphamide and etoposide as singlecourse re-induction therapy for children with refractory/ multiple relapsed acute lymphoblastic leukaemia. Br J Haematol 2009;47: 371-378.

2-Kantarjian HM, Gandhi V, Kozuch P, et al. Phase I clinical and pharmacology study of clofarabine in patients with solid and hematologic cancers. J Clin Oncol. 2003;21:1167-1173. 

3-Kantarjian H, Gandhi V, Cortes J, et al. Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia. Blood. 2003;102:2379-2386.

4-Renato Bassan, Monica Fumagalli, Sabina Chiaretti,et.al. Phase II trial with sequential clofarabine and cyclophosphamide for refractory and relapsed philadelphia-negative adult acute lymphoblastic leukemia. Results of the GIMEMA LAL 1610 protocol. Leukemıa & Lymphoma 2019, Vol. 60, No. 14, 3482–3492.